[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
January 21, 2004

Novel Risk Factors for Atherosclerosis

Author Affiliations
 

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(3):301. doi:10.1001/jama.291.3.301-a

To the Editor: In their review article, Drs Hackam and Anand1 discussed the 4 novel risk factors of C-reactive protein, lipoprotein(a) [Lp(a)], fibrinogen, and homocysteine to predict atherosclerosis. The authors concluded that their optimal use remains to be determined.

Because of the high negative predictive value of classic risk factors2,3 there appears to be no need to screen for these novel risk factors as primary prevention. However, there is a need to improve risk estimation in groups of individuals with high and intermediate risk.4 In contrast to the conclusions of Hackam and Anand, we have reported that an Lp(a) level greater than 30 mg/dL (1.07 µmol/L) further increases the risk of men at intermediate and high estimated global risk.5

First Page Preview View Large
First page PDF preview
First page PDF preview
×